ASH1L and bone neoplasm: Of note, inhibiting ASH1L only impaired bone tumor outgrowth in the presence of macrophages, while depletion of macrophages abolished these effects (Fig. 7b, c and Supplementary Fig. 9a), suggesting TAMs are required for ASH1L’s pro-metastatic role.